Ribosomal Incorporation of Intercalators into Peptides and Proteins in Living Organisms

At the University of Konstanz a novel method with very high selectivity has been developed, which allows the inclusion of amino acids with nucleic acid-intercalating properties into proteins and peptides. Protein- and peptide-based active pharmaceutical components often contain structures that act as intercalators. The technology uses standard protein expression methods and only requires the presence of the ncAA in the medium and the co-expression of the respective aminoacyl-tRNA synthetases as well as the tRNA. The invention has substantial potential for the development of new applications and products, in particular in the pharmaceutical and biotech fields.

Further information: PDF

Technologie-Lizenz-Büro (TLB) der Baden-Württembergischen Hochschulen GmbH
Phone: +49 (0)721/79 00 40

Contact
Dipl.-Biol. Marcus Lehnen, MBA

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Recovering phosphorus from sewage sludge ash

Chemical and heat treatment of sewage sludge can recover phosphorus in a process that could help address the problem of diminishing supplies of phosphorus ores. Valuable supplies of phosphorus could…

Efficient, sustainable and cost-effective hybrid energy storage system for modern power grids

EU project HyFlow: Over three years of research, the consortium of the EU project HyFlow has successfully developed a highly efficient, sustainable, and cost-effective hybrid energy storage system (HESS) that…

After 25 years, researchers uncover genetic cause of rare neurological disease

Some families call it a trial of faith. Others just call it a curse. The progressive neurological disease known as spinocerebellar ataxia 4 (SCA4) is a rare condition, but its…

Partners & Sponsors